Azabicyclo [3. 2. I] octyl derivatives as 11 beta-HSDL modulators

Details for Australian Patent Application No. 2009223693 (hide)

Owner Exelixis, Inc.

Inventors Schweiger, Edwin; Bollu, Venkataiah; Dalgard, Jackline Eve; Huang, Ping; Mohan, Raju; Martin, Richard; Flatt, Brenton T.; Wang, Tie Lin

Agent Davies Collison Cave

Pub. Number AU-A-2009223693

PCT Pub. Number WO2009/114173

Priority 61/203,720 23.12.08 US; 61/069,648 14.03.08 US

Filing date 13 March 2009

Wipo publication date 17 September 2009

International Classifications

C07D 451/04 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

30 September 2010 PCT application entered the National Phase

  PCT publication WO2009/114173 Priority application(s): WO2009/114173

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009223701-Substituted heterocycle fused gammacarbolines solid

2009223688-Compositions and methods for the therapy and diagnosis of cytomegalovirus infections